Biogened S.A. (WSE:BGD)
Poland
· Delayed Price · Currency is PLN 19.50
+0.10 (0.52%)
At close: Apr 28, 2026
Biogened Revenue
In the year 2025, Biogened had annual revenue of 114.04M PLN with 2.81% growth. Biogened had revenue of 28.19M in the quarter ending December 31, 2025, a decrease of -3.68%.
Revenue
114.04M
Revenue Growth
+2.81%
P/S Ratio
0.42
Revenue / Employee
584.83K
Employees
184
Market Cap
47.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.04M | 3.11M | 2.81% |
| Dec 31, 2024 | 110.93M | 15.37M | 16.09% |
| Dec 31, 2023 | 95.56M | 15.94M | 20.02% |
| Dec 31, 2022 | 79.62M | 14.30M | 21.89% |
| Dec 31, 2021 | 65.32M | 16.99M | 35.15% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MakoLab Spólka Akcyjna | 77.94M |
| Prymus | 42.13M |
| Telestrada | 55.96M |
| ORGANIC Farma Zdrowia | 134.43M |
| BioMaxima | 59.11M |
| CDRL S.A. | 260.17M |
| Caspar Asset Management | 48.66M |
| Outdoorzy | 10.11M |